Your session is about to expire
← Back to Search
Behavioral Intervention
GO MOVE Home Program for Cerebral Palsy
N/A
Recruiting
Led By Angela Shierk, PhD
Research Sponsored by Texas Scottish Rite Hospital for Children
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Age 3-17 years old
Diagnosis of unilateral CP or a non-progressive brain lesion, injury, or trauma of the developing brain presenting with a unilateral upper limb motor impairment
Must not have
Inability to complete the assessment protocol or home program
Uncontrolled epilepsy
Timeline
Screening 3 weeks
Treatment Varies
Follow Up within 2 weeks of end of intervention (post-intervention)
Awards & highlights
No Placebo-Only Group
Summary
This trial will evaluate a mobile website that helps people with cerebral palsy set goals and complete exercises to meet those goals. Participants will spend 1:15/week for 6 weeks and complete assessments before and after.
Who is the study for?
This trial is for children and teens aged 3-17 with unilateral cerebral palsy who can follow directions, use a personal device to access the Go Move website, and are not restricted by their doctor from daily activities. It's open to all ethnic/racial groups. Those with severe visual impairments, uncontrolled epilepsy, or behavioral issues cannot participate.
What is being tested?
The study tests the acceptability and effectiveness of 'Go Move', a mobile site designed to help youth with unilateral cerebral palsy set goals and choose exercises. Participants will engage in a home program for over an hour weekly for six weeks while using Go Move.
What are the potential side effects?
Since this intervention involves goal-setting and exercise guidance through a website without medication or invasive procedures, significant side effects are not anticipated. However, typical exercise-related discomforts may occur.
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowSelect...
I am between 3 and 17 years old.
Select...
I have cerebral palsy or a brain injury affecting one side of my body.
Select...
I can walk without limitations or with some limitations.
Exclusion Criteria
You may be eligible for the trial if you check “No” for criteria below:Select...
I cannot follow the study's required assessments or home activities.
Select...
I have epilepsy that is not well-controlled.
Select...
I have major difficulty seeing.
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ within 2 weeks of start of intervention (pre-intervention), within 2 weeks of end of intervention (post-intervention)
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~within 2 weeks of start of intervention (pre-intervention), within 2 weeks of end of intervention (post-intervention)
Treatment Details
Study Objectives
Study objectives can provide a clearer picture of what you can expect from a treatment.Primary study objectives
Canadian Occupational Performance Measure (COPM)
Secondary study objectives
Assisting Hand Assessment (AHA) (optional)
Goal Attainment Scale (GAS) Light
Other study objectives
Demographic information
Feasibility and satisfaction with using the Go Move website
Gross Motor Function Classification System (GMFCS)
+2 moreAwards & Highlights
No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.
Trial Design
1Treatment groups
Experimental Treatment
Group I: Go Move Home ProgramExperimental Treatment1 Intervention
Goal driven home program
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Home Program
2023
N/A
~180
Find a Location
Who is running the clinical trial?
Texas Scottish Rite Hospital for ChildrenLead Sponsor
21 Previous Clinical Trials
8,972 Total Patients Enrolled
4 Trials studying Cerebral Palsy
94 Patients Enrolled for Cerebral Palsy
Angela Shierk, PhDPrincipal InvestigatorScottish Rite for Children
2 Previous Clinical Trials
50 Total Patients Enrolled
2 Trials studying Cerebral Palsy
50 Patients Enrolled for Cerebral Palsy